Press release
Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 Products In The Liraglutide Market
Liraglutide
The increasing diabetic population is expected to propel the liraglutide market. Diabetes, particularly type 2, is on the rise due to factors like sedentary lifestyles, unhealthy diets, and obesity. Liraglutide, a drug that mimics the GLP-1 hormone to regulate blood sugar, plays a significant role in managing diabetes. In March 2023, the UK's NHS reported a rise in type 1 diabetes care processes, signaling a growing need for diabetes management. This surge in diabetes cases is driving the liraglutide market.
Get Your Liraglutide Market Report Here:
https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report
What is the projected compound annual growth rate (CAGR) of the liraglutide market from 2025 to 2034, and what factors influence it?
The liraglutide market will grow from $6.38 billion in 2024 to $6.95 billion in 2025 at a CAGR of 9.0%, supported by increasing type 2 diabetes cases, obesity rates, and innovations in diabetes treatments.
The liraglutide market is projected to reach $9.66 billion by 2029, growing at a CAGR of 8.6%. Growth is attributed to healthcare infrastructure development, rising diabetes prevalence, and expanding insurance coverage. Trends include AI-driven research, wearable technology integration, continuous glucose monitoring, and digital health platform advancements.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp
How are the latest trends influencing the growth of the liraglutide market?
Major companies in the liraglutide market are introducing new products like generic GLP-1 drugs to expand treatment options and meet the growing demand for affordable alternatives. Generic GLP-1 drugs are versions of GLP-1 receptor agonists that are produced once the patent for the original branded medications expires, offering a more cost-effective treatment option for conditions like type 2 diabetes and obesity. For instance, in June 2024, Teva Pharmaceutical Industries Ltd., an Israeli pharmaceutical company, launched the first generic version of GLP-1, similar to Victoza, in the U.S. This new option aims to meet the increasing demand for these therapies, offering liraglutide injections to manage blood sugar in adults and children over 10 with type 2 diabetes, and to reduce the risk of cardiovascular events in adults with both type 2 diabetes and heart disease.
What are the major segments of the liraglutide market and their role in driving growth?
The liraglutide market covered in this report is segmented -
1) By Brands: Victoza, Saxenda
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies
3) By Type Of Application: Diabetes Treatment, Weight Management
4) By End-Users: Hospitals And Clinics, Homecare Settings
Subsegments:
1) By Victoza: Type 2 Diabetes Treatment Or Weight Management
2) By Saxenda: Weight Loss Treatment Or Obesity Management
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18659
Which regions are key players in the growth of the liraglutide market?
North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the liraglutide market?
Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=18659&type=smp
What Is Covered In The Liraglutide Global Market Report?
•Market Size Forecast: Examine the liraglutide market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the liraglutide market for a structured understanding.
•Key Players Overview: Analyze major players in the liraglutide market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the liraglutide market.
•Segment Contributions: Evaluate how different segments drive overall growth in the liraglutide market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the liraglutide market.
•Industry Challenges: Identify potential risks and obstacles affecting the liraglutide market.
•Competitive Landscape: Review strategic developments in the liraglutide market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 Products In The Liraglutide Market here
News-ID: 3927099 • Views: …
More Releases from The Business Research Company
Metalworking Fluids Market Analysis: $17.82 Billion by 2029 With a CAGR of 7.2%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Metalworking Fluids Market Value Projection: How Much Will the Market Size by 2025?
The market size of metalworking fluids has been on a steady rise in the past few years. The market, which is projected to increase from $12.91 billion in 2024 to $13.5 billion in 2025, boasts a compound annual…
Male Toiletries Industry Set to Achieve $36.54 Billion Milestone by 2029 | Stead …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Male Toiletries Market Size 2025?
Over the past years, there's been a consistent rise in the size of the male toiletries market. It is projected to expand from $27.6 billion in 2024 to $28.73 billion in 2025, presenting a compound annual growth rate (CAGR)…
Ink Resin Industry Expected to Reach $7.86 Billion by 2029 at 12% CAGR
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Ink Resin Market Value Projection: How Much Will the Market Size by 2025?
The market for ink resin has seen substantial growth in the past few years. The market size, which stood at $4.56 billion in 2024, is predicted to reach $5 billion in 2025, with a CAGR of 9.8%. This…
Impact Modifiers Industry Growth Outlook: 9.3% CAGR and $7.06 Billion by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Impact Modifiers Market Size 2025?
The market size for impact modifiers has been witnessing robust expansion in the past few years. The market will escalate from $4.61 billion in 2024, surging to $4.95 billion in 2025 at a Compound Annual Growth Rate (CAGR) of…
More Releases for Liraglutide
Impact Of Diabetic Population Growth On The Liraglutide Market: Critical Driver …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Liraglutide Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for liraglutide has seen substantial growth in recent years. The market size, which is expected to be at $6.38 billion in 2024, is projected to inflate to $6.95 billion in 2025, with a Compound…
Rising Diabetes Prevalence Drives Growth in Liraglutide and Semaglutide Markets …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Liraglutide And Semaglutide Industry Market Size Be by 2025?
In recent times, the liraglutide and semaglutide market has seen quick and impressive growth. The growth is projected to continue, with the market size increasing from $15.19 billion in 2024 to an estimated $16.98 billion in 2025,…
Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 P …
"What Are the Projections for the Size and Growth Rate of the Liraglutide Market?
The market for liraglutide has seen robust expansion in the past few years. The market is projected to escalate from $6.38 billion in 2024 to $6.95 billion in 2025, representing a compound annual growth rate (CAGR) of 9.0%. This surge during the historic period can be linked to the rising numbers of individuals being identified with type…
Liraglutide Market Analysis 2024: Trends, Growth Drivers, and Key Players
"Gain a competitive edge with up to 30% off in-depth market reports-uncover key trends, growth drivers, and forecasts today!
The new report published by The Business Research Company, titled Liraglutide Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the liraglutide…
Liraglutide Market Analysis 2019 and Industry Insights in the Future
QY Research always aims at offering their clients an in-depth analysis and the best research material of the various market. This new report on the global Liraglutide market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts.
Request a Sample of this report at
http://www.qyresearchglobal.com/goods-1906246.html
Key Manufacturers:
HEC…
Global Liraglutide Market Top Companies in Liraglutide 2019 - HEC Pharm ,Teva ,B …
Researchreport.Biz Leading Research Firm has added the latest report on "Global Liraglutide Market by Manufacturers, Regions, Type, and Application, Forecast to 2024".
The purpose of "Global Liraglutide Market" report is to provide the newest industry data and Liraglutide industry future trends, allowing consumers to identify the Liraglutide market Application, Type, Manufacturers and Regions, Liraglutide market Forecast period 2019-2024.
The scope of Global Liraglutide Market Report:
2019 "Worldwide Liraglutide Market" lists the ruling vendors…
